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An association between heavy alcohol drinking and gastric cancer risk has been recently reported, but the issue is still open
to discussion and quantification. We investigated the role of alcohol drinking on gastric cancer risk in the “Stomach cancer
Pooling (StoP) Project,” a consortium of epidemiological studies. A total of 9,669 cases and 25,336 controls from 20 studies
from Europe, Asia and North America were included. We estimated summary odds-ratios (ORs) and the corresponding 95%
confidence intervals (CIs) by pooling study-specific ORs using random-effects meta-regression models. Compared with
abstainers, drinkers of up to 4 drinks/day of alcohol had no increase in gastric cancer risk, while the ORs were 1.26 (95% CI,
1.08–1.48) for heavy (>4 to 6 drinks/day) and 1.48 (95% CI 1.29–1.70) for very heavy (>6 drinks/day) drinkers. The risk for
drinkers of >4 drinks/day was higher in never smokers (OR 1.87, 95% CI 1.35–2.58) as compared with current smokers (OR
1.14, 95% CI 0.93–1.40). Somewhat stronger associations emerged with heavy drinking in cardia (OR 1.61, 95% CI 1.11–
2.34) than in non-cardia (OR 1.28, 95% CI 1.13–1.45) gastric cancers, and in intestinal-type (OR 1.54, 95% CI 1.20–1.97)
than in diffuse-type (OR 1.29, 95% CI 1.05–1.58) cancers. The association was similar in strata of H. pylori infected
(OR51.52, 95% CI 1.16–2.00) and noninfected subjects (OR51.69, 95% CI 0.95–3.01). Our collaborative pooled-analysis
provides definite, more precise quantitative evidence than previously available of an association between heavy alcohol drink-
ing and gastric cancer risk.
The World Health Organization’s global survey on alcohol and
health conducted in 20121 reported that around the world
almost 40% of people regularly drink alcohol, one of the major
avoidable risk factors for cancer.2 Worldwide, in 2012, 5.5% of
all cancer cases were attributed to alcohol drinking,3 with an
increase of 1.5% in the decade 2002–2012, largely due to the
global increase in drinking prevalence and amount of alcohol
consumed in several areas of the world.
Despite a steady fall in incidence over the last several dec-
ades,4,5 there are still about one million new diagnoses of gas-
tric cancer per year worldwide, and gastric cancer remains
the third leading cause of cancer mortality.6 Gastric cancer is
a multi-factorial disease, involving genetic and environmental
factors, and Helicobacter pylori (H. pylori) infection has been
recognized as the major aetiological factor.7
In 2009, a working group of the International Agency for
Research on Cancer (IARC) concluded that there was inade-
quate evidence for a role of alcohol in gastric cancer carcino-
genesis.8 Recent data, however, suggested that heavy alcohol
drinking is associated with an increased risk of gastric can-
cer.9,10 A recent study showed that an increased risk was
only observed in the absence of H. pylori infection,11 while in
H. Pylori infected people moderate alcohol consumption may
act as an antimicrobial, favoring suppression and eventual
elimination of H. pylori infection.11,12 In April 2016, the
World Cancer Research Fund International concluded for a
probable increased gastric cancer risk for alcohol intakes of
about three drinks or more per day.13
Most individual studies are, however, underpowered to
accurately investigate the dose-response relationship between
alcohol drinking and gastric cancer risk, and the differences
in risk according to subsite or histological subtype, or in
strata of effect modiﬁers.
The “Stomach cancer Pooling (StoP) Project,”14 a recently
established consortium of epidemiological studies on risk factors
for gastric cancer, represents a unique opportunity to better
deﬁne and quantify the association between alcohol drinking
and gastric cancer risk, using subject-level information.
Material and Methods
All participating studies previously received ethical approval
from their local Institutional Review Boards (IRBs). For the
collaborative re-analysis, ad hoc approval was obtained from
the University of Milan IRB.
Studies identification and data standardization
The ﬁrst release of the StoP Project dataset included 23 case-
control studies for a total of 10,290 gastric cancer cases
(6,804 men, 3,486 women) and 26,153 controls (15,604 men,
10,549 women).15 Out of 23 studies, 20 had data on alcohol
consumption (Supporting Information Table S1): one from
Greece,16 four from Italy,17–20 one from Portugal,21 one from
What’s new?
How strong is the association between alcohol and gastric cancer risk? These authors pooled data from 20 epidemiological
studies worldwide to quantify the connection. People who drank up to four alcoholic drinks a day, they found, had similar risk
to those who abstained. Those who took more than four drinks per day saw their risk rise by 20%, while those who imbibed
most heavily—6 or more drinks per day—boosted their risk by 50%, or for non-smokers, nearly doubled their risk. Further-
more, they saw the same association with or without H. pylori infection.
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Table 1. Distribution of 9,669 cases of stomach cancer and 25,336 controls according to study center, sex, age and other selected
covariates
Cases Controls
N % N %
Total 9,669 25,336
Study center (Reference)
Europe 5,079 52.5 12,664 50.0
Greece (Lagiou et al., 2004)16 110 1.1 100 0.4
Italy 1 (La Vecchia et al., 1995)19 769 8.0 2,081 8.2
Italy 2 (Lucenteforte et al., 2008)20 230 2.4 547 2.2
Italy 3 (De Feo et al., 2012)18 160 1.7 444 1.8
Italy 4 (Buiatti et al., 1989)17 1,016 10.5 1,159 4.6
Portugal (Lunet et al., 2007)21 692 7.2 1,667 6.6
Russia (Zaridze et al., 2000)22 450 4.7 611 2.4
Spain 1 (Castano-Vinyals et al., 2015)23 441 4.6 3,440 13.6
Spain 2 (Santibanez et al., 2012)24 401 4.1 455 1.8
Sweden 1 (Harris et al., 2013)25 88 0.9 352 1.4
Sweden 2 (Harris et al., 2013)25 161 1.7 644 2.5
Sweden 3 (Ye et al., 1999)26 561 5.8 1,164 4.6
Asia 2,576 26.6 5,419 21.4
China 1 (Deandrea et al., 2010)27 266 2.8 533 2.1
China 2 (Mu et al., 2005)28 206 2.1 415 1.6
China 3 (Setiawan et al., 2005)29 711 7.4 711 2.8
China 4 (Setiawan et al., 2000)30 133 1.4 433 1.7
Japan (Matsuo et al., 2013)31 1,260 13.0 3,327 13.1
North America 2,014 20.8 7,253 28.6
Canada (Mao et al., 2002)32 1,182 12.2 5,039 19.9
USA (Zhang et al., 1999)33 132 1.4 132 0.5
USA (unpublished data, J. Muscat) 700 7.2 2,082 8.2
Sex
Male 6,357 65.7 15,036 59.3
Female 3,312 34.3 10,300 40.7
Age
<40 341 3.5 1,901 7.5
40–45 350 3.6 1,521 6.0
45–50 594 6.1 1,976 7.8
50–54 954 9.9 2,624 10.4
55–59 1,271 13.1 3,044 12.0
60–64 1,519 15.7 3,914 15.4
65–69 1,747 18.1 4,125 16.3
70–75 1,740 18.0 3,701 14.6
75 1,153 11.9 2,522 10.0
Missing 0 0.0 8 0.0
Social class
Low 5,135 53.1 10,270 40.5
Intermediate 2,516 26.0 7,606 30.0
High 1,201 12.4 5,335 21.1
Missing 817 8.4 2,125 8.4
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Russia,22 two from Spain,23,24 three from Sweden (two of
which were nested in cohort studies),25,26 four from
China,27–30 one from Japan,31 one from Canada32 and two
from the USA (one of which with unpublished data, J. Mus-
cat),33 including a total of 9,669 cases and 25,336 controls.
For two cohort studies included in the StoP Project consor-
tium, the Swedish Mammography Cohort and the Cohort of
Swedish Men,25 a nested case-control design was used by
selecting four controls for each case, matched on age.
All data were collected and harmonized according to a
prespeciﬁed format at the pooling center. Questionnaires on
alcohol were comparable across studies. Subjects were asked
about their lifetime alcohol drinking habits (drinkers or not),
and, if not abstainers, about current status (ex or current
drinker), frequency and [in eight studies19–22,24,27,30 and USA
2 (unpublished data, J. Muscat)] duration of drinking,
amount of alcohol consumed overall and according to spe-
ciﬁc beverages, i.e., beer, wine and hard liquor, and (in six
studies18,21,22,24,27,31) time since quitting alcohol drinking.
When information on red and white wine consumption was
collected separately,17,23 we considered the combined intake,
while nonalcoholic beer was not considered. The Russian
study22 collected information on vodka drinking, that was
considered a hard liquor. Two studies29,30 provided informa-
tion on lifetime alcohol drinking status (i.e., never/ever) only.
Each variable was checked for illogical or missing values, and
any inconsistency was resolved by contacting study
investigators.
The average lifetime daily number of ethanol-standardized
drinks (i.e., 1 drink5 12 grams of pure ethanol) was computed
applying estimates of the beverage-speciﬁc volume percentage
of pure ethanol (5% for beer, 12% for wine, 40% for liquor),
and categorized across studies as 1, >1 to 4, >4 to 6, >6 to
8 and >8 drinks/day, in order to investigate the effect of high
levels of alcohol drinking on gastric cancer risk, while minimiz-
ing the occurrence of sparse data within the upper category.
The amount of pure ethanol per day was also analyzed as a con-
tinuous variable using ﬂexible regression modeling to overcome
problems related to variable categorization. Moreover, for spe-
ciﬁc beverages, we identiﬁed mutually exclusive subgroups of
beer, wine or hard liquor only drinkers, with never drinkers as
a common reference group. Categories were deﬁned to avoid
sparse data. For wine, numbers allowed to deﬁne three levels of
drinking (1, >1 to 3 and >3 drinks/day), since European
populations consumed larger quantities of wine than American
and Asian ones.
Duration of drinking was categorized as never drinkers,
20, >20 to 40 and >40 years, while time since quitting
drinking alcohol as 5, >5 to 10 and >10 years, using
current drinkers as reference category.
Table 1. Distribution of 9,669 cases of stomach cancer and 25,336 controls according to study center, sex, age and other selected covari-
ates (Continued)
Cases Controls
N % N %
History of stomach cancer in first degree relatives1
No 4,694 48.5 12,439 49.1
Yes 827 8.6 1,244 4.9
Missing 4,148 42.9 11,653 45.9
Vegetables and fruit intake2
Low 2,875 29.7 6,721 26.5
Intermediate 2,929 30.3 7,419 29.3
High 2,826 29.2 7,854 31.0
Missing 1,039 10.7 3,342 13.2
Tobacco smoking
Never 3,869 40.0 11,151 44.0
Former 2,733 28.3 7,405 29.2
Current (cigarettes equivalent/day) 2,708 28.5 6,265 24.9
10 623 6.4 1,758 6.9
10–20 1,206 12.5 2,600 10.3
>20 924 9.6 1,959 7.7
Missing 314 3.2 463 1.8
1No information available for studies China 1 (Deandrea et al., 2010),27 Canada (Mao et al., 2002),32 China 3 (Setiawan et al., 2005),29 USA (unpub-
lished data, J. Muscat), Sweden 1 (Harris et al. 2013)25 and Sweden 2 (Harris et al., 2013).25
2No information available for studies USA (unpublished data, J. Muscat) and China 4 (Setiawan et al., 2000).30
StoP Project consortium.
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Table 2. Pooled ORs and 95% CIs for gastric cancer according to average lifetime alcohol drinking
Cases Controls
N % N % OR (CI 95%)1 I2 (p for heterogeneity)
Alcohol drinking status 9,669 25,336
Never alcohol drinker 2,613 27.0 6,862 27.1 1 –
Ever alcohol drinker 6,759 69.9 17,266 68.1 1.10 (0.99–1.21) 47.5% (0.01)
Missing 297 3.1 1,208 4.8
Alcohol drinking intensity2 8,825 24,192
Never alcohol drinker 2,096 23.8 6,117 25.3 1 –
 1 drink/day 2,239 25.4 7,816 32.3 1.00 (0.86–1.16) 62.1% (<0.01)
>1 to 4 drinks day 2,632 29.8 5,812 24.0 1.11 (1.01–1.23) 17.5% (0.25)
>4 to 6 drinks/day 521 5.9 1,075 4.4 1.26 (1.08–1.48) 11.9% (0.32)
>6 drinks/day 650 7.3 1,023 4.2 1.48 (1.29–1.70) 0% (0.63)
>6 to 8 drinks/day 275 3.1 455 1.9 1.46 (1.18–1.80) 17.1% (0.28)
>8 drinks/day 375 4.2 568 2.3 1.50 (1.26–1.78) 0% (0.99)
Missing 687 7.8 2,349 9.7
p Value for trend <0.01
Never drinkers1Wine only drinkers3 3,135 8,369
Never alcohol drinker 1,619 51.6 4,866 58.1 1 –
>0 to 1 882 28.1 2,147 25.7 1.03 (0.80–1.31) 65.6% (<0.01)
>1 to 3 410 13.1 895 10.7 1.22 (1.02–1.45) 0% (0.82)
>3 216 6.9 437 5.2 1.44 (0.98–2.11) 25.4% (0.23)
Missing 8 0.3 24 0.3
p Value for trend 0.18
Never drinkers1 beer only drinkers3 1,920 5,854
Never alcohol drinker 1,619 84.2 4,866 83.1 1 –
>0 to 1 215 11.0 728 12.4 1.33 (0.97–1.83) 41.4% (0.04)
>1 65 3.6 188 3.2 1.27 (0.89–1.82) 0% (0.60)
Missing 21 1.2 72 1.2
p Value for trend 0.21
Never drinkers1spirits only3 2,094 5,828
Never alcohol drinker 1,619 77.3 4,866 83.5 1 –
>0 to 1 253 12.1 686 11.8 0.94 (0.70–1.27) 35.9% (0.09)
>1 208 9.9 249 4.3 1.66 (1.23–2.22) 4.4% (0.39)
Missing 14 0.7 27 0.5
p Value for trend 0.06
Alcohol drinking duration (years)4 3,641 8,409
Never drinker 894 24.6 2,427 28.9 1 –
>0 to 20 276 7.6 952 11.3 1.02 (0.84–1.23) 1.4% (0.42)
>20 to 40 1,044 28.7 2,097 24.9 1.28 (1.08–1.51) 24.3% (0.24)
>40 802 22.0 1,202 14.3 1.13 (0.97–1.33) 0% (0.94)
Missing 625 17.2 1,731 20.6
p Value for trend <0.01
Years since quitting alcohol drinking5 2,307 4,745
Current drinker 1,887 81.8 4,119 86.8 1 –
>0 to 5 269 11.7 267 5.6 1.93 (1.39–2.68) 52.4% (0.06)
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We also collected information on a list of additional varia-
bles to be introduced as confounders and to deﬁne stratiﬁed
analyses, including H. pylori infection data, whenever available
(Supporting Information Table S1).
Statistical analysis
We used a two-stage modeling approach.34 At the ﬁrst stage,
we assessed the association between alcohol drinking and gas-
tric cancer by estimating for each study the odds ratios (ORs)
and the corresponding 95% conﬁdence intervals (CIs) using
multivariable unconditional logistic regression models. We ﬁt-
ted polytomous unconditional logistic regression model when
analyzing the association by cancer subsite and histological
type. These models included, when available (i.e., <30% of
missing values ahead of multiple imputation) and appropriate
(see Supporting Information Table S1), terms for age (<40, 40–
44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74 and 75 years),
sex, education/social class (study-speciﬁc low, intermediate,
high), race/ethnicity (White, Hispanic/Latino, Black/African
American, other), tobacco smoking (never, former, current
10 cigarettes/day, >10 to 20 cigarettes/day and >20 ciga-
rettes/day), fruit and vegetable consumption (study-speciﬁc ter-
tiles) and study center (for multicentric studies). To account for
sporadically missing values in study-speciﬁc confounders, we
applied multiple imputation using full chained equations.35
Brieﬂy, assuming that data were missing at random, ﬁve
imputed datasets were generated for each study, and missing
entries ﬁlled in with a set of plausible values drawn from the
posterior predictive distribution of the missing data conditional
on the observed data. The imputation models were congenial
with the analysis models and included the same set of covari-
ates plus the disease status. A logistic (polytomous for cancer
subsite and histological type), regression model was then ﬁtted
in each of the ﬁve imputed dataset, and the resulting sets of
model estimates were combined through the Rubin’s rule to
obtain study speciﬁc regression coefﬁcients and their standard
errors. In the second stage, summary (pooled) effects estimates
were computed using a random-effect model.36
Heterogeneity between studies was evaluated using the Q
test statistics and quantiﬁed using I2, i.e., the proportion of
total variation contributed by between-study variance.37
The decision to adopt a two-stage analytical approach in
the consortium was taken a priori.14 As a sensitivity analysis,
we carried out a one-stage analysis through a multivariable
unconditional logistic regression model, adjusted for study
and the aforementioned covariates.
We carried out several stratiﬁed analyses to investigate the
effect of alcohol drinking across strata of selected covariates:
age ( 55, >55 to 65, >65), sex, cigarette smoking (never,
former, current), socioeconomic status (low, intermediate,
high), geographic area (Europe, Asia, America), cancer sub-
site (cardia, non cardia), histological type (intestinal, diffuse
and undifferentiated), H. pylori infection status (positive and
negative) and type of controls (hospital-based, population-
based; controls from 2 nested case-control studies were con-
sidered together with the latter). For H. pylori infection, we
also carried out a restricted analysis by comparing H. pylori
positive controls with all cases, under the assumption that
H. pylori infection is a necessary cause for gastric cancer.14 In
all the strata, alcohol drinking was categorized as never
drinkers, 1, >1 to 4 and >4 drinks/day, to avoid sparse
data in the highest category, being never drinkers the refer-
ence category. A p values for heterogeneity within levels of
each potential effect modiﬁer was computed, and the interac-
tion was tested through a meta-regression model considering
the variable as ordinal.
We tested for the signiﬁcance of linear trends across levels
of alcohol drinking by estimating study-speciﬁc trends (i.e.,
considering the variable as ordinal in the logistic model), and
using the Wald test p values deriving from the summary
random-effects estimate.34
Further, we modeled the functional form of the relation
between grams of alcohol per day (continuously) and gastric
cancer risk using one-order and two-order fractional polyno-
mial models. The method was based on a two-stage proce-
dure. In a ﬁrst step, we ﬁtted ﬁrst-order and second-order
Table 2. Pooled ORs and 95% CIs for gastric cancer according to average lifetime alcohol drinking (Continued)
Cases Controls
N % N % OR (CI 95%)1 I2 (p for heterogeneity)
>5 to 10 41 1.8 86 1.8 1.00 (0.66–1.53) 0% (0.64)
>10 49 2.1 87 1.8 0.84 (0.56–1.25) 0% (0.58)
Missing 61 2.6 186 3.9
p Value for trend 0.43
1Pooled ORs were computed using random-effects models. Study-specific ORs were adjusted, when available, for sex, age, race/ethnicity, social
class, tobacco smoking, fruit and vegetable consumption and study center for multicentric studies.
2Information was not available for studies China 3 (Setiawan et al., 2005)29 and China 4 (Setiawan et al., 2000).30
3Information was not available for studies China 3 (Setiawan et al., 2005)29 and Japan (Matsuo et al., 2013).31
4Considered studies: Italy 1 (La Vecchia et al., 1995),19 Italy 2 (Lucenteforte et al., 2008),20 Portugal (Lunet et al., 2007),21 Russia (Zaridze et al., 2000),22
Spain 2 (Santibanez et al., 2012),24 China 1 (Deandrea et al., 2010),27 China 4 (Setiawan et al., 2000)30 and USA (unpublished data, J. Muscat).
5Considered studies: Italy 3 (De Feo et al., 2012),18 Portugal (Lunet et al., 2007),21 Russia (Zaridze et al., 2000),22 Spain 2 (Santibanez et al., 2012),24
China 1 (Deandrea et al., 2010)27 and Japan (Matsuo et al., 2013).31
StoP Project consortium
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fractional polynomial models to each study adjusting for the
aforementioned confounders. This family of models includes
the linear one. In the second step, the pooled dose-risk rela-
tion was estimated through a bivariate random effects
model.38 The best ﬁtting model, i.e., the one minimizing the
model deviance, was selected when the best ﬁtting model was
non linear.39
The ﬁrst step of the analysis was carried out through ad-hoc
developed macros in SAS 9.4 using PROC MI and PROC
MIANALIZE procedures for the multiple imputation task. The
“meta” package40 of R version 3.1.2 was used to perform the
(second stage) random-effects meta-regression model.
Results
The main characteristics of the 9,669 gastric cancer cases
and 25,336 controls included in the present analysis are
reported in Table 1. Approximately half of the cases and
controls were from European studies. About two-thirds of
gastric cancer cases (65.7%) were men, and cases were
somewhat older (median age 64 years) than controls
(median age 62), and more frequently of lower social classes
(53.1 vs. 40.5%). They also had more frequently than con-
trols a history of stomach cancer in ﬁrst degree relatives
(8.6 vs. 4.9%), and were more frequently current smokers
(28.5 vs. 24.9%).
Figure 1. Study-specific and pooled ORs and corresponding 95% CIs of gastric cancer risk for light (1 drink/day) (a), moderate (>1 to 4
drinks) (b), heavy (>4 to 6 drinks) (c) and very heavy (>6 drinks/day) (d) average lifetime alcohol drinking compared with never drinkers.
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The pooled ORs of gastric cancer according to alcohol drink-
ing are given in Table 2. Approximately 70% of cases and 68% of
controls, reported ever consuming alcohol, with a pooled OR of
1.10 (95% CI, 0.99–1.21) as compared to never drinkers. When
analyzing drinking intensity (Fig. 1), we found a signiﬁcant asso-
ciation between heavy drinking and gastric cancer risk, the ORs
for >4 up to 6 drinks/day being 1.26 (95% CI, 1.08–1.48), and
1.48 (95% CI, 1.29–1.70) for consumption of >6 drinks/day as
compared with never drinkers, with a signiﬁcant trend in risk
(p< 0.01). When data were analyzed through an aggregated
dataset with a one-stage approach, results were materially
unchanged, the ORs being 1.29 (95% CI, 1.14–1.47) for>4 up to
6 drinks/day and 1.48 (95% CI, 1.31–1.68) for>6 drinks/day.
The distribution of beverage consumption differed sub-
stantially. Among drinkers of only one type of beverage, wine
was the most common reported beverage (66.1 and 64.2%
among cases and controls, respectively), followed by spirits
(20.7 and 17.6% among cases and controls, respectively) and
beer (13.1 and 18.1% among cases and controls, respectively).
A signiﬁcant excess risk was found for spirits-only drinkers
of >1 drink/day (pooled OR 1.66, 95% CI 1.23–2.22), while the
pooled OR was 1.44 (95% CI 0.98–2.11) for wine-only drinkers
of >3 drinks/day and 1.27 (95% CI 0.89–1.82) for beer-only
drinkers of >1 drink/day, in the absence, however, of a signiﬁ-
cant trend (Table 2).
Data on duration of alcohol drinking were available in a
total of 8 studies. A signiﬁcant increased risk (pooled OR
1.28, 95% CI 1.08–1.51) of gastric cancer was observed for
subjects drinking alcohol from >20 to 40 years, while the
pooled ORs for the highest duration of consumption (>40
years) was 1.13 (95% CI, 0.97–1.33). We found a signiﬁcant
excess risk for subjects quitting drinking for <5 years (pooled
OR 1.93, 95% CI 1.39–2.68), taking current drinkers as a
reference, then the risk decreased towards unity.
Figure 1. (Continued)
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The best ﬁtting dose rate-risk relationship between average
lifetime alcohol drinking and gastric cancer risk was
ln(OR)522.65E-6dose221 0.003518dose (Fig. 2). The
random-effects pooled model-based estimates of the OR were
1.02 (95% CI, 1.01–1.03), 1.11 (95% CI, 1.05–1.17), 1.24
(95% CI, 1.11–1.38), 1.34 (95% CI, 1.15–1.57) and 1.42 (95%
CI, 1.15–1.57) for consumption of 6 (i.e., 1 drink/day), 30
(i.e., >1 to 4 drinks/day), 60 (i.e., >4 to 6 drinks/day), 84
(i.e., >6 to 8 drinks/day) and 100 (i.e., >8 drinks/day) grams
of alcohol per day, respectively.
Stratiﬁed analyses according to drinking intensity are
reported in Table 3. No signiﬁcant differences in risk estimates
were observed by sex, age and geographic area, while never
smokers drinking >4 drinks/day had almost a two-fold excess
risk of gastric cancer (OR 1.87, 95% CI 1.35–2.58). Although
pooled estimates did not signiﬁcantly differ across levels of
socioeconomic status, an increased risk for heavy drinkers (OR
1.47, 95% CI 1.21–1.79) was evident for subjects with low
socioeconomic status. When considering heavy drinkers, risks
were somewhat higher for cardia (OR 1.61, 95% CI 1.11–2.34)
than non-cardia (OR 1.28, 95% CI 1.13–1.45) gastric cancers
and in intestinal-type (OR 1.54, 95% CI 1.20–1.97) than in
diffuse-type (OR 1.29, 95% CI 1.05–1.58) gastric cancers. Simi-
lar pooled estimates were observed in H. pylori infected (heavy
drinkers, OR5 1.52, 95% CI 1.16–2.00) and non-infected
(heavy drinkers, OR5 1.69, 95% CI 0.95–3.01) subjects, while
the pooled OR for heavy drinkers was 1.42 (95% CI 1.11–1.83)
when the analysis was restricted to H. pylori positive controls
(all cases supposed to be infected). In addition, in the restricted
group of non-cardia gastric cancer cases, H. pylori infected
heavy drinkers (OR5 1.39, 95% CI 1.10–1.76) and non-
infected heavy drinkers, (OR5 1.39, 95% CI 0.88–2.20) sub-
jects had similar gastric cancer risks. No differences in risk esti-
mates were found between studies with controls enrolled in
hospital (heavy drinkers, OR5 1.33, 95% CI 1.12–1.59) and
those in the general population (heavy drinkers, OR5 1.47,
95% CI 1.18–1.82).
Similar results emerged in stratiﬁed analyses when consid-
ering wine only drinkers (Supporting Information Table S2).
Discussion
This uniquely large collaborative pooled analysis in the StoP
Project consortium found an association between heavy alcohol
drinking (deﬁned as consumption of >4 drinks/day, approxi-
mately 50 g/day of ethanol) and the risk of gastric cancer. A sig-
niﬁcant excess risk of 50% emerged for drinkers of >6
drinks/day. Adjustment for socioeconomic status and fruit and
vegetables consumption allows for possible confounding by
poor nutrition, an established gastric cancer risk factor associ-
ated with heavy alcohol drinking.41 Notably, when stratifying
by socioeconomic status, no signiﬁcant differences in pooled
estimates emerged. When considering drinkers of each speciﬁc
type of beverages only, we found a signiﬁcantly increased risk
for spirits-only drinkers, even though in our data the most
commonly consumed beverage was wine. No consistent rela-
tion was observed for duration of alcohol drinking, and the risk
of quitters was not reduced as compared with current drinkers.
This is not surprising, since for alcohol drinking the effect of
duration is less clear than that of dose also on strongly alcohol-
related cancers, such as head and neck neoplasms.42
Our results are in the wave of an accumulating evidence of
an association between heavy alcohol drinking and gastric can-
cer risk.9–11,43 A meta-analysis by Tramacere et al.10 – based on
15 cohort and 44 case-control studies – found a 20% increased
risk of gastric cancer (RR 1.20, 95% CI 1.01–1.44) for 4 or more
alcoholic drinks per day, consistent with our results, but was
unable to investigate the role of higher alcohol doses, nor the
effects of speciﬁc beverages. The European Prospective Investi-
gation into Cancer and Nutrition (EPIC) study9 found a signiﬁ-
cant hazard ratio (HR) of 1.65 (95% CI 1.06–2.58) for ethanol
intake measured at baseline, and a HR of 1.50 (95% CI 0.90–
2.51) for average lifetime drinking of >60 g/day, in line with
our ﬁndings. A recent report from the Korean Multi-center
Cancer Cohort11 found a HR of 1.36 (95% CI 0.95–1.96) for a
consumption of >55 g per occasion, and interestingly, using a
case-cohort design, a HR of 3.27 (95% CI 1.01–10.56) in H.
pylori non-infected heavy drinkers, although based on a few
cases only. Our ﬁndings, however, do not support a different
effect of heavy alcohol drinking in subjects infected and nonin-
fected by H. pylori.
Results from stratiﬁed analyses did not show a substantial
difference between geographic regions in the magnitude of
risk for the highest consumption level. The 60% not signiﬁ-
cant excess risk observed in Asian studies suggests a gene-
environment interaction between ALDH2 and alcohol
Figure 2. Best fitting fractional polynomial model (continuous line)
with its 95% CIs (dashed lines) describing the dose rate-risk
relationship between average lifetime alcohol drinking and gastric
cancer risk. ORs (represented by squares) and their 95% CIs
(represented by vertical bars) estimates deriving from the
categorical analysis are also reported.
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Table 3. Pooled ORs and 95% CIs for gastric cancer according to alcohol drinking in strata of sex, age, cigarette smoking, socioeconomic status, geographic area, cancer site, cancer
histotype, H. Pylori infection and controls recruitment
Never Light drinkers (1 drink/day)
Moderate drinkers (>1 to 4
drinks/day) Heavy drinkers (>4 drinks/day)
Ca:Co Ca:Co OR (95% CI) Ca:Co OR (95% CI) Ca:Co OR1 (95% CI) p2 p3
Overall 2,096:6,117 2,239:7,816 1.00 (0.86–1.16) 2,632:5,812 1.11 (1.01–1.23) 1,171:2,098 1.36 (1.22–1.52) <0.01
Sex
Men 846:2,376 1,416:4,346 1.02 (0.85–1.22) 1,995:4,383 1.10 (0.98–1.24) 1,113:1,967 1.44 (1.24–1.68) 0.53 0.17
Women 1,250:3,741 823:3,470 0.99 (0.83–1.18) 637:1,429 1.11 (0.92–1.33) 58:131 1.41 (0.97–2.06) 0.50
Age
55 576:2,116 538:2,708 0.89 (0.66–1.19) 624:1,810 1.13 (0.85–1.51) 353:827 1.73 (1.14–2.63) 0.17 0.44
>55 to 65 590:1,687 625:2,047 0.98 (0.79–1.20) 840:1,827 1.07 (0.91–1.25) 411:732 1.22 (1.00–1.49) 0.65
>65 930:2,311 1,076:3,060 1.09 (0.89–1.34) 1,168:2,175 1.16 (1.02–1.33) 407:539 1.49 (1.23–1.82) 0.91
Cigarette smoking
Never 1,280:3,863 837:3,381 1.03 (0.82–1.28) 832:1,909 1.14 (0.97–1.33) 239:393 1.87 (1.35–2.58) 0.08 0.25
Former 375:1,165 738:2,574 1.10 (0.86–1.40) 890:2,104 1.41 (1.09–1.83) 384:752 1.64 (1.10–2.44) <0.01
Current 399:1,028 567:1,713 0.91 (0.76–1.10) 821:1,708 0.93 (0.78–1.12) 524:933 1.14 (0.93–1.40) 0.95
Socioeconomic status4
Low 940:2,232 1,143:3,040 0.99 (0.83–1.19) 1,449:2,216 1.11 (0.97–1.27) 511:678 1.47 (1.21–1.79) 0.96 0.67
Intermediate 442:1,441 471:2,114 0.90 (0.75–1.08) 597:1,515 1.10 (0.87–1.39) 311:639 1.25 (0.80–1.96) 0.01
High 180:962 325:1,796 0.85 (0.57–1.26) 236:1,093 1.11 (0.83–1.47) 101:318 1.31 (0.90–1.90) 0.01
Geographic area
Europe 958:2,666 1,232:4,019 1.07 (0.87–1.33) 1,921:3,730 1.19 (1.05–1.35) 741:1,269 1.34 (1.14–1.58) 0.59 0.54
Asia 736:1,786 331:979 0.83 (0.70–0.98) 340:936 0.98 (0.71–1.36) 258:467 1.59 (0.87–2.90) 0.03
North America 402:1,665 676:2,818 1.07 (0.87–1.33) 371:1,146 1.08 (0.90–1.29) 172:362 1.46 (1.14–1.85) 0.70
Site5
Cardia 172:5,582 355:7,541 0.97 (0.65–1.44) 312:5,730 1.00 (0.81–1.24) 179:2,077 1.61 (1.11–2.34) 0.05 0.19
Non cardia 1,606:5,582 1,634:7,541 0.98 (0.84–1.15) 2,195:5,730 1.16 (0.94–1.44) 936:2,077 1.28 (1.13–1.45) 0.61
Histotype6
Intestinal 397:4,792 477:6,672 0.99 (0.72–1.37) 758:4,745 1.13 (0.95–1.35) 249:1,617 1.54 (1.20–1.97) 0.89 0.35
Diffuse 531:4,792 465:6,672 1.01 (0.85–1.21) 557:4,745 1.03 (0.88–1.20) 282:1,617 1.29 (1.05–1.58) 0.94
Undifferentiated 536:4,792 596:6,672 0.78 (0.67–0.89) 695:4,745 1.14 (0.88–1.47) 306:1,617 1.50 (1.23–1.83) 0.59
H. pylori infection7
H. pylori positive 374:870 413:1,340 0.77 (0.63–0.96) 444:1,092 1.14 (0.92–1.41) 321:478 1.52 (1.16–2.00) 0.45 0.24
H. pylori negative 185:516 152:491 0.86 (0.60–1.23) 123:318 0.97 (0.46–2.07) 114:189 1.69 (0.95–3.01) 0.11
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Table 3. Pooled ORs and 95% CIs for gastric cancer according to alcohol drinking in strata of sex, age, cigarette smoking, socioeconomic status, geographic area, cancer site, cancer
histotype, H. Pylori infection and controls recruitment (Continued)
Never
Light drinkers (1 drink/day)
Moderate drinkers (>1 to 4
drinks/day) Heavy drinkers (>4 drinks/day)
Ca:Co Ca:Co OR (95% CI) Ca:Co OR (95% CI) Ca:Co OR1 (95% CI) p2 p3
Only H. pylori positive
controls8
942:870 938:1,340 0.75 (0.60–0.94) 823:1,092 0.94 (0.79–1.12) 644:478 1.42 (1.11–1.83) 0.16
H. pylori infection in noncardia gastric cancer cases9
H. pylori positive 320:813 338:1,289 0.81 (0.69–0.95) 395:1,092 1.01 (0.84–1.23) 280:478 1.39 (1.10–1.76) 0.61 0.89
H. pylori negative 94:389 89:391 0.89 (0.64–1.25) 105:318 1.11 (0.68–1.82) 89:189 1.39 (0.88–2.20) 0.59
Only H. pylori positive
controls8
771:813 754:1,289 0.79 (0.60–1.05) 736:1,092 0.96 (0.79–1.16) 554:478 1.43 (1.09–1.87) 0.45
Controls10
Hospital based 1,193:3,148 879:2,149 1.22 (0.97–1.54) 1,021:2,446 1.14 (0.97–1.34) 663:1,237 1.33 (1.12–1.59) 0.24 0.73
Population based 802:2,803 1,346:5,634 0.84 (0.72–0.98) 1,468:3,204 1.05 (0.92–1.20) 336:625 1.47 (1.18–1.82) 0.50
1Pooled ORs were computed using random-effects models. Study-specific ORs were adjusted, when available and feasible, for sex, age, race/ethnicity, social class, tobacco smoking, fruit and
vegetable consumption and study center for multicentric studies.
2p Values for test of OR heterogeneity across studies.
3p Values for test of interaction derived from a meta-regression model.
4The studies Italy 3 (De Feo et al., 2012)18 and Japan (Matsuo et al., 2013)31 were not considered due to a high fraction of missing values for socioeconomic status.
5The studies China 1 (Deandrea et al., 2010)27 and China 2 (Mu et al., 2005)28 were not considered as they did not collect data on cancer subsite.
6The studies Greece (Lagiou et al., 2004),16 Italy 1 (La Vecchia et al., 1995),19 Sweden 1 (Harris et al., 2013),25 Sweden 2 (Harris et al. 2013),25 China 1 (Deandrea et al. 2010)27 and China 2 (Mu
et al. 2005)28 were not considered as they did not collect data on histological type.
7Considered studies: Portugal (Lunet et al., 2007),21 Russia (Zaridze et al., 2000),22 Spain 1 (Castano-Vinyals et al., 2015),23 Sweden 3 (Ye et al., 1999),26 China 2 (Mu et al., 2005)28 and Japan
(Matsuo et al., 2013).31 The studies Italy 3 (De Feo et al., 2012)18 and Spain 2 (Santibanez et al., 2012)24 were not considered because no information on H. pylori infection was available for con-
trols, or controls were all H. pylori negative.
8Pooled ORs were computed considering all cases and only controls positive to H. pylori infection.
9Considered studies: Portugal (Lunet et al., 2007),21 Russia (Zaridze et al., 2000),22 Spain 1 (Castano-Vinyals et al., 2015),23 Sweden 3 (Ye et al., 1999)26 and Japan (Matsuo et al., 2013).31
10The Russian study (Zaridze et al., 2000)22 was not considered in this analysis because it included both hospital and general population controls.
Ca, cases; Co, controls.
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consumption.31 ALDH2 polymorphisms were found to mod-
ify the susceptibility to the development of gastric cancer
associated with alcohol intake, especially in case of ALDH2
*1/*2 genotype.44
This pooled analysis reported similar ﬁndings in men and
women and across various age groups. When considering
heavy drinkers (>4 drinks/day), we found an almost two-fold
increased risk in never smokers (OR 1.87 95% CI 1.35–2.58),
while the corresponding risks in former (OR 1.64, 95% CI
1.10–2.44) and current smokers (OR 1.14, 95% CI 0.93–1.40)
were lower. This ﬁnding suggests no or marginal confound-
ing by smoking status, and argues against the hypothesis that
the excess risk in heavy drinkers is due to the correlation
between heavy alcohol drinking and tobacco smoking, an
established risk factor for gastric cancer risk.15
Only a few studies investigated the relation between alcohol
drinking and gastric cancer by anatomic location (cardia vs. non-
cardia gastric cancer),9,10,45 or according to histological type.9
Our data showed somewhat stronger associations for heavy
drinking in cardia (OR 1.61, 95% CI 1.11–2.34) than in noncar-
dia (OR 1.28, 95% CI 1.13–1.45) gastric cancers and in
intestinal-type (OR 1.54, 95% CI 1.20–1.97) than in diffuse-type
(OR 1.29, 95% CI 1.05–1.58) cancers. Regarding cancer subsite,
our results are in contrast with those of the EPIC study,9 that
found a three-fold increased risk for noncardia cancers for con-
sumption of 60 g/day or more of alcohol, and no signiﬁcantly
increased risk for cardia cancers, while the Netherlands Cohort
Study45 did not ﬁnd any difference. When analyzing cancer his-
tological type, the EPIC study reported an increased, although
not signiﬁcant, risk (HR 1.95) for intestinal-type cancers, in the
absence of association for diffuse-type cancer. Our results were
based on over 6,000 noncardia and 1,000 cardia gastric cancer
cases, and over 1,800 cases each of intestinal and diffuse histolog-
ical type of gastric cancer.
When analyzing the dose rate-risk relationship using ﬂexible
models—i.e. by considering alcohol as a continuous variable—
we found that the best ﬁtting fractional polynomial was the one
with powers (–2,1), showing a linear trend without a threshold
effect,9,43 which resulted in an estimated 4% signiﬁcant increased
risk of gastric cancer for every additional drink of alcohol per
day.
Our results showed an almost two fold excess risk among
former drinkers who had stopped drinking for <5 years, but
the risk decreased towards unity afterwards. This apparently
paradoxical ﬁnding could be partly explained by the fact that
some cases could have quit drinking after the onset of symp-
toms or immediately after the diagnosis of gastric cancer (i.e.,
reverse causation).46
The mechanisms by which (heavy) alcohol consumption exerts
its carcinogenic effect are various and not fully understood. Acet-
aldehyde, the ﬁrst metabolite of ethanol, is a human carcinogen
able to induce DNA lesions, generate free radicals and bind to
enzymes involved in DNA repair and antioxidant protection.47
Moreover, chronic and heavy (40 g/day) intake of alcohol mark-
edly induces expression of cytochrome P-4502E1 (CYP2E1) in the
gastrointestinal mucosa of rodents and in humans,48 contributing
to the formation of reactive oxygen species in the gastrointestinal
tract, and to the activation of procarcinogens like nitrosamines. It
should be also recognized that the nutritional status of heavy
drinkers is impaired due to primary and secondary malnutrition,
leading to deﬁciencies of core nutrients that in turn may contrib-
ute to the carcinogenic process.48
Our analyses included studies with hospital controls, which
are more prone to selection bias, but the results were consistent
across different sources of study controls. Moreover, differences
across studies in the formulation of their questions on lifetime
alcohol consumption may represent a source of heterogeneity.
In 13 out of 20 studies19–21,23–25,27–31 including the one with
unpublished data, never drinkers were deﬁned as lifelong
abstainers, while in the remaining 7 studies16–18,22,26,32,33 as
long time (i.e. up to 20 years) non-drinkers including infre-
quent occasional drinkers (<1 times per month). It is however
unlikely that this had meaningfully inﬂuenced our results.
Underreporting of alcohol intake may also have affected
our results, since social acceptance of alcohol consumption
may vary across countries, as well as consumption of speciﬁc
beverages and their ethanol content.49 However, no substan-
tial inconsistencies emerged across studies, particularly in
heavy drinkers, as conﬁrmed by the low I2 statistic for het-
erogeneity between studies.
The “StoP Project” includes original and individual data on
alcohol drinking on 10,000 cases and 26,000 controls and pro-
vide us a unique opportunity to investigate and accurately quan-
tify the dose rate-risk relationship between alcohol drinking and
gastric cancer risk, overall and in strata of potential confounders,
or according to tumor location and histology. The individual
level approach has several advantages as compared with study-
level meta-analysis, speciﬁcally the availability of detailed and
uniform information on important covariates.50
We were able to adjust for socioeconomic status and con-
sumption of fruit and vegetables in the majority of studies, and
we investigated the possible confounding effect of H. pylori
infection. These sensitivity analyses conﬁrmed the results of
the main analysis, thus providing further evidence of a role of
heavy alcohol drinking independent from that of H. pylori.
In conclusion, the results of this pooled-analysis of
epidemiological studies support a detrimental, although mod-
est, effect of heavy alcohol drinking on gastric cancer risk. The
almost two-fold increased risk in heavy drinkers among never
smokers, as well as the consistent results when restricting the
analyses to H. pylori positive subjects, support an independent
role of heavy alcohol drinking on gastric cancer risk.
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